Sterling Capital Management’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$48.2K Buy
666
+596
+851% +$46.2K ﹤0.01% 1780
2026
Q2
$4.81K Sell
70
-53
-43% -$3.01K ﹤0.01% 2644
2026
Q1
$7.9K Sell
123
-2
-2% -$182 ﹤0.01% 2500
2025
Q4
$16.3K Buy
125
+79
+172% +$10.8K ﹤0.01% 2343
2025
Q3
$4.96K Buy
46
+1
+2% +$109 ﹤0.01% 2764
2025
Q2
$4.15K Sell
45
-149
-77% -$11.7K ﹤0.01% 2612
2025
Q1
$17.2K Sell
194
-158
-45% -$13.7K ﹤0.01% 1698
2024
Q4
$27.1K Buy
352
+316
+878% +$22.1K ﹤0.01% 1786
2024
Q3
$1.53K Buy
+36
New +$1.22K ﹤0.01% 2323

Other funds holding WGS

Sterling Capital Management's WGS Position: Q3 2026 in Review

Sterling Capital Management increased its GeneDx Holdings (WGS) stake by 851% in Q3 2026, buying an estimated $46.2K and bringing the position to 666 shares worth $48.2K. The position accounts for ﹤0.01% of the portfolio, ranked #1780.

Sterling Capital Management first reported a position in WGS in Q3 2024 and has held it in 9 quarters since. 218 funds tracked by Wall St. Rank hold WGS as of Q3 2026.

  • Sterling Capital Management held 666 shares of GeneDx Holdings worth $48.2K as of Q3 2026.
  • Sterling Capital Management bought 596 GeneDx Holdings shares in Q3 2026, an estimated $46.2K.
  • GeneDx Holdings made up ﹤0.01% of Sterling Capital Management's portfolio in Q3 2026, its #1780 holding.
  • Sterling Capital Management first reported a position in GeneDx Holdings in Q3 2024 and has held it in 9 quarters since.
  • 218 funds tracked by Wall St. Rank held GeneDx Holdings as of Q3 2026.

Based on Sterling Capital Management's 13F filing for Q3 2026, filed 22 Oct 2026.